Vildagard M 50/850 mg Tablet (15 Tab)

About Vildagard M 50/850 mg Tablet:

Vildagard M 50/850 mg tablet is a combination of two anti-diabetic medications, used to treat type 2 diabetes mellitus. It helps to control the high blood glucose levels.

Each film coated Vildagard M 50/850 mg tablet contains Vildagliptin 50 mg and Metformin Hydrochloride 850 mg.

Vildagliptin selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme that rapidly truncates and inactivates incretin hormones such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Incretin hormones increase insulin synthesis and decrease glucagon release in a manner dependent on glucose concentrations. These effects lead to an overall increase in blood glucose control.

Metformin is a biguanide antihyperglycemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Use of Vildagard M 50/850 mg Tablet:

Vildagard M 50/850 mg tablet is prescribed for the treatment of patients with type 2 diabetes mellitus.

Usage direction of Vildagard M 50/850 mg Tablet:

• Vildagard M 50/850 mg tablet should be taken orally.
• Vildagard M 50/850 mg tablet is taken whole with the help of water.
• Do not crush, chew or break the tablet.
• Do not stop or skip the medicine without physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Vildagard M 50/850 mg Tablet:

• If allergic to this medicine, inform the physician immediately.
• If find any other complication inform the physician immediately.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.
• It is dangerous to take this preparation except under medical supervision.

Storage condition of Vildagard M 50/850 mg Tablet:

Store between 8°C to 25°C. Protect from moisture.